Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000353569-21-000054
Filing Date
2021-05-07
Accepted
2021-05-06 18:03:44
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20210331.htm   iXBRL 10-Q 943310
2 EX-31.1 ex31120210331.htm EX-31.1 9796
3 EX-31.2 ex31220210331.htm EX-31.2 9907
4 EX-32.1 ex32120210331.htm EX-32.1 5706
  Complete submission text file 0000353569-21-000054.txt   4876599

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20210331.xsd EX-101.SCH 33859
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20210331_cal.xml EX-101.CAL 72677
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20210331_def.xml EX-101.DEF 155490
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20210331_lab.xml EX-101.LAB 497421
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20210331_pre.xml EX-101.PRE 303605
10 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20210331_htm.xml XML 730498
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-10961 | Film No.: 21899419
SIC: 2835 In Vitro & In Vivo Diagnostic Substances